Vitexin-2''-O-rhamnoside structure
|
Common Name | Vitexin-2''-O-rhamnoside | ||
---|---|---|---|---|
CAS Number | 64820-99-1 | Molecular Weight | 578.519 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | 898.8±65.0 °C at 760 mmHg | |
Molecular Formula | C27H30O14 | Melting Point | 215ºC | |
MSDS | Chinese USA | Flash Point | 299.5±27.8 °C |
Use of Vitexin-2''-O-rhamnosideVitexin-2-O-rhamnoside, a main flavonoid glycoside of the leaves of Cratagus pinnatifida Bge, contributes to the protection against H2O2-mediated oxidative stress damage and has potential to treat cardiovascular system diseases[1]. |
Name | vitexin 2''-O-α-L-rhamnoside |
---|---|
Synonym | More Synonyms |
Description | Vitexin-2-O-rhamnoside, a main flavonoid glycoside of the leaves of Cratagus pinnatifida Bge, contributes to the protection against H2O2-mediated oxidative stress damage and has potential to treat cardiovascular system diseases[1]. |
---|---|
Related Catalog | |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 898.8±65.0 °C at 760 mmHg |
Melting Point | 215ºC |
Molecular Formula | C27H30O14 |
Molecular Weight | 578.519 |
Flash Point | 299.5±27.8 °C |
Exact Mass | 578.163574 |
PSA | 239.97000 |
LogP | 1.86 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.751 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xn |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
Bioorg. Med. Chem. 19 , 2090-102, (2011) Flavonoids are an interesting group of natural products ubiquitously present in human diet. Their consumption has been associated with various and differing beneficial health effects. However, several... |
(1S)-1,5-Anhydro-2-O-(6-deoxy-β-D-mannopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol |
8-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one |
Vitexin-2-O-rhamnoside |
vitexin 2''-O-alpha-L-rhamnoside |
8-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxyméthyl)-3-{[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-méthyltétrahydro-2H-pyran-2-yl]oxy}tétrahydro-2H-pyran-2-yl]-5,7-dihydroxy-2-(4-hydroxyphényl)-4H-chromén-4-one |
8-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-on |
(1S)-1,5-Anhydro-2-O-(6-désoxy-β-D-mannopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphényl)-4-oxo-4H-chromén-8-yl]-D-glucitol |
Apigenin-8-C-glucoside-2'-rhamnoside |
D-Glucitol, 1,5-anhydro-2-O-(6-deoxy-β-D-mannopyranosyl)-1-C-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]-, (1S)- |
Vitexin-2"-O-rhamnoside |
8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |
Vitexin 2''-O-rhamnoside |